Olszowy named CTO at ViroCyt
Last Updated: 15:28 June 11, 2014
ViroCyt develops instrumentation and reagents that allow for the quantification of virus particles in a given sample in just minutes.
The company was founded in early 2013 as a spinoff of Boulder-based InDevR Inc., and was originally based in Denver before moving to Boulder in November.
Olszowy, who has a doctorate in experimental pathology, comes to ViroCyt from Thermo Fisher Scientific, where he was instrumental in the launch of the Attune acoustic focusing cytometer. At ViroCyt, he will lead the company’s efforts to evolve its Virus Counter technology.
“Dr. Olszowy brings to ViroCyt an outstanding record of development of innovative products in the bioscience field,” ViroCyt chief executive Robert Kline said in a release.
More breaking news...
Amgen shutting down Boulder, Longmont sites
Mapleton property sold twice in 7 months
Colorado sees record visitor numbers in 2013
Mapleton Hill Investments LLC, registered to Don Altman, a partner of AGR
The 2013 spending figure represents an increase of 5 percent over 2012, in which the state hosted 57.9 million visitors who spent